Brief: Bliss GVS Pharma Approves Increase Of Foreign Portfolio Investors/Foreign Institutional Investors Limits To 74 Pct In Co
Feb 25 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS :
* APPROVED INCREASE OF FOREIGN PORTFOLIO INVESTORS/FOREIGN
INSTITUTIONAL INVESTORS LIMITS FROM 24% TO 74% IN CO
Source text: http://bit.ly/2Ebfk7b
Further company coverage: BLIS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees